Dabigatran vs

Dabigatran is also used to treat and prevent blood clots (eg, deep vein thrombosis, pulmonary embolism) from occurring again in patients who already have received other medicines. It is also used to prevent deep vein thrombosis and pulmonary embolism after hip replacement surgery. Dabigatran (Pradaxa) is a drug prescribed to reduce the risk of blood clots in the heart of individuals with atrial fibrillation. Pradaxa also is used to treat deep vein thrombosis and pulmonary embolism. Dabigatran is an anticoagulant that works by blocking the clotting protein thrombin. Dabigatran is used to prevent blood clots from forming because of a certain irregular heart rhythm (atrial fibrillation). Preventing these blood clots helps to reduce the risk of a stroke. Dabigatran is an anticoagulant that works by blocking a clotting protein called thrombin in the blood. This helps to stop clots from forming and keeps blood flowing smoothly in the body. Dabigatran, a direct thrombin inhibitor, has robust data for the treatment of deep venous thrombosis and pulmonary embolism, stroke prevention in non-valvular atrial fibrillation, and the prophylaxis of venous thromboembolism (VTE) after knee and hip replacement. Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [6][7] It is commonly used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. What is this medication? DABIGATRAN (DA bi GAT ran) prevents and treats blood clots. It is also used to lower the risk of stroke in people with Afib (atrial fibrillation). It belongs to a group of medications called blood thinners. Medscape - VTE prevention/treatment dosing for Pradaxa (dabigatran), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost. What is dabigatran? Dabigatran is used to treat blood clots deep in the body (deep vein thrombosis, DVT) and lungs (pulmonary embolism, PE) in adults who have received blood thinners by injection for 5 to 10 days. Dabigatran etexilate mesylate, also known by its brand name, Pradaxa, is a type of anticoagulant blood thinner that treats and prevents certain types of blood clots in people ages 8 years and older. It's also used to lower the risk of stroke and blood clots in people with atrial fibrillation (AFib).

Meta: